Abstract
The inhibition of hepatic glycogen-associated protein phosphatase-1 (PP1-G(L)) by glycogen phosphorylase a prevents the dephosphorylation and activation of glycogen synthase, suppressing glycogen synthesis when glycogenolysis is activated. Here, we show that a peptide ((280)LGPYY(284)) comprising the last five amino acids of G(L) retains high-affinity interaction with phosphorylase a and that the two tyrosines play crucial roles. Tyr284 deletion abolishes binding of phosphorylase a to G(L) and replacement by phenylalanine is insufficient to restore high-affinity binding. We show that a phosphorylase inhibitor blocks the interaction of phosphorylase a with the G(L) C-terminus, suggesting that the latter interaction could be targeted to develop an anti-diabetic drug.
| Original language | English |
|---|---|
| Pages (from-to) | 4749-4753 |
| Number of pages | 5 |
| Journal | FEBS Letters |
| Volume | 581 |
| Issue number | 24 |
| DOIs | |
| Publication status | Published - 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Amino Acid Sequence
- Animals
- Calorimetry
- Glycogen Phosphorylase, Liver Form
- Humans
- Indoles
- Mice
- Molecular Sequence Data
- Mutation
- Phenylbutyrates
- Protein Binding
- Protein Subunits
- Rabbits
- Rats
- Thermodynamics
- Titrimetry
- Tyrosine
Fingerprint
Dive into the research topics of 'The hepatic PP1 glycogen-targeting subunit interaction with phosphorylase a can be blocked by C-terminal tyrosine deletion or an indole drug'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver